v3.25.2
ACCRUED LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2025
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following as of June 30, 2025 and December 31, 2024:
(In thousands)
JUNE 30,
2025
DECEMBER 31,
2024
CRO and clinical trial costs
$
6,689
$
18,968
Manufacturing activities
15,260
11,839
Professional legal and accounting fees
1,008
475
Interest payable
—
2,186
Gross-to-net adjustments
1,184
1,166
Other
2,153
915
Total Accrued Liabilities
$
26,294
$
35,549
X
- References
No definition available.
+ Details
Name:
us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details
Name:
us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:
us-gaap_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration